Answers are grounded in this paper and cite their sources.
Introduction Aplastic anemia (AA) is a rare and life-threatening bone marrow failure (BMF) disorder commonly attributed to immune-mediated destruction of hematopoietic stem and progenitor cells (HSPCs) in the bone marrow (BM). Current understanding of AA is predominantly derived from studies in adult cohorts, leaving the mechanisms contributing to pediatric AA incompletely defined. In children, identification of immune-mediated AA is further complicated by histological and immunophenotypic overlap with inherited BMF syndromes (IBMFS) and the lack of reliable biomarkers. Methods In this study, we characterized the immune cell composition and spatial interactions in the blood and BM of pediatric AA and IBMFS using flow cytometry and spatial proteomics, to evaluate the classification of pediatric AA as an immune-mediated form of BMF. Results Peripheral blood counts of pediatric AA showed significant reduction in memory T-cells and NK-cells, whereas these cells were preserved or elevated in the BM, suggesting infiltration into the BM. Although the absolute number of lymphocytes in the BM was similar between AA and IBMFS, their spatial organization differed with AA displaying lymphoid-enriched regions with colocalization of T-cells. This pattern was rarely observed in (hypoplastic) IBMFS cases, despite shared features of BM hypoplasia and local stress, suggesting an AA-specific disease process. Discussion Collectively, our study reveals a distinct immune signature in pediatric AA, characterized by immune redistribution to the BM and a spatially coordinated, T-cell-dominated immune response. As such, our findings provide insight into immune pathways driving pediatric BMF.
No takes yet. Share an insight, caveat, or question.
Vissers et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: